News FDA takes big step towards manufacturing harmonisation with ... FDA agrees to recognise some EU inspections for the first time
Views & Analysis Pharma and med device sectors being forced into Hard Brexit ... Brexit is already forcing parts of the medical device sector to leave the UK – will pharma have to follow?
Views & Analysis PRIME movers: taking stock of the EMA's scheme Taking stock of one PRIME, of the EMA’s flagship market access initiatives.
News Bungled Brexit move would trigger public health crisis, warn... Regulator could be crippled by staff exodus during relocation.
News FDA and EMA reach milestone in sharing confidential informat... New agreement is culmination of three years of work by FDA and EMA
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
